PVP and surfactant combined carrier as an effective absorption enhancer of poorly soluble astilbin in vitro and in vivo
PVP and surfactant combined carrier as an effective absorption enhancer of poorly soluble astilbin in vitro and in vivo
复制标题
PVP与表面活性剂复合载体作为难溶性落新妇苷体内外有效吸收促进剂
DOI:
10.3109/03639045.2012.756008
复制
发表时间:
2014-01
期刊:
影响因子:
--
通讯作者:
He Y, Liu H, Xie Z, Liao Q, Lai X, Du Z.
中科院分区:
文献类型:
--
作者:
He Y, Liu H, Xie Z, Liao Q, Lai X, Du Z.
Abstract Context: Astilbin is considered to be a new and promising immunosuppressant for immune related diseases, but limited in clinical application due to its poor water solubility, difficult oral absorption and low bioavailability. Objective: The present work studied the effect of PVP and surfactant combined carrier on its capability to improve drug absorption. Materials and methods: PVP K30-Tween 80 combined carries was applied into the astilbin solid dispersions, tested both in vivo in beagle dogs and in vitro in transport experiments across Caco-2 cell monolayers. Results and discussion: In the animal studies a many fold increase in plasma AUC was observed for the solid dispersions of drug in PVP K30-Tween 80 combined carries compared to active pharmaceutical ingredient (API). The applicability of Caco-2 monolayers as a tool for predicting the in vivo transport behavior of Astilbin in combination with a solubility enhancing carries was shown. In vitro transport studies confirmed the effect of combined carries on the absorption behavior of the astilbin. MTT studies showed the cell viability gradually decreased with the increase of the drug concentration in a dose dependent manner for astilbin and that in solid dispersions. The permeability and apparent permeability coefficients (Papp) increased with drug in the Caco-2 cell. Conclusion: In this study, it was found that PVP K30 and Tween 80 promoted the permeability of drugs best within a certain amount. For astilbin PVP K30 and surfactant combined carrier had a strong potential to improve oral bioavailability.
登录
查看更多内容
影响因子:
--
作者:
Zou Jie-ming
通讯作者:
Zou Jie-ming
DOI:
10.3109/13880209309082916
发表时间:
1993
期刊:
--
影响因子:
--
作者:
Eliane Carneiro;J. Calixto;F. Monache;R. Yunes
通讯作者:
Eliane Carneiro;J. Calixto;F. Monache;R. Yunes
DOI:
10.4268/cjcmm20100612
发表时间:
2010-03
期刊:
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
影响因子:
--
作者:
Chao Wang;Liping Zhu;Jing-zhi Yang;Chuang-jun Li;Dongming Zhang
通讯作者:
Chao Wang;Liping Zhu;Jing-zhi Yang;Chuang-jun Li;Dongming Zhang
DOI:
--
发表时间:
1998-11
期刊:
Yao xue xue bao = Acta pharmaceutica Sinica
影响因子:
--
作者:
Y. Yi;Z. Cao;D. Yang;Y. Cao;Y. Wu;S. Zhao
通讯作者:
Y. Yi;Z. Cao;D. Yang;Y. Cao;Y. Wu;S. Zhao
影响因子:
3.4
作者:
S. Vithlani;S. Sarraf;C. Chaw
通讯作者:
S. Vithlani;S. Sarraf;C. Chaw